Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia.

Mortimer A, Martin S, Lôo H, Peuskens J; SOLIANOL Sudy Group.

Int Clin Psychopharmacol. 2004 Mar;19(2):63-9.

PMID:
15076013
2.

Amisulpride compared with standard neuroleptics in acute exacerbations of schizophrenia: three efficacy studies.

Freeman HL.

Int Clin Psychopharmacol. 1997 May;12 Suppl 2:S11-7. Review.

PMID:
9218163
3.

Practical issues with amisulpride in the management of patients with schizophrenia.

Pani L, Villagrán JM, Kontaxakis VP, Alptekin K.

Clin Drug Investig. 2008;28(8):465-77. Review.

PMID:
18598092
4.

Which role for amisulpride in rehabilitation of schizophrenic patients with acute exacerbation?

Blin O.

Encephale. 2000 Oct;26 Spec No 1:7-11. Review. English, French.

PMID:
11294060
5.

Amisulpride: progress and outcomes.

Lecrubier Y.

Curr Med Res Opin. 2002;18 Suppl 3:s18-22. Review.

PMID:
12418608
6.

Amisulpride for schizophrenia.

Mota NE, Lima MS, Soares BG.

Cochrane Database Syst Rev. 2002;(2):CD001357. Review.

PMID:
12076408
7.

Amisulpride: a review of its use in the management of schizophrenia.

McKeage K, Plosker GL.

CNS Drugs. 2004;18(13):933-56. Review.

PMID:
15521794
8.

Amisulpride: a review of its use in the management of schizophrenia.

Curran MP, Perry CM.

Drugs. 2001;61(14):2123-50. Review.

PMID:
11735643
9.

Antipsychotic medication, functional outcome and quality of life in schizophrenia: focus on amisulpride.

Nuss P, Tessier C.

Curr Med Res Opin. 2010 Apr;26(4):787-801. doi: 10.1185/03007990903576953. Review.

PMID:
20121655
10.

Amisulpride: a review of its efficacy in schizophrenia.

Möller HJ.

Acta Psychiatr Scand Suppl. 2000;400:17-22. Review.

PMID:
10823307
11.

Spotlight on amisulpride in schizophrenia.

Curran MP, Perry CM.

CNS Drugs. 2002;16(3):207-11. Review.

PMID:
11888341
12.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
13.

Clinical update on amisulpride in deficit schizophrenia.

Rein W, Turjanski S.

Int Clin Psychopharmacol. 1997 May;12 Suppl 2:S19-27. Review.

PMID:
9218164
14.

[Prescription of olanzapine in children and adolescent psychiatric patients].

Frémaux T, Reymann JM, Chevreuil C, Bentué-Ferrer D.

Encephale. 2007 Mar-Apr;33(2):188-96. Review. French.

PMID:
17675914
15.

Aripiprazole versus other atypical antipsychotics for schizophrenia.

Khanna P, Suo T, Komossa K, Ma H, Rummel-Kluge C, El-Sayeh HG, Leucht S, Xia J.

Cochrane Database Syst Rev. 2014 Jan 2;(1):CD006569. doi: 10.1002/14651858.CD006569.pub5. Review.

PMID:
24385408
16.

How do we choose between atypical antipsychotics? The advantages of amisulpride.

Mortimer AM.

Int J Neuropsychopharmacol. 2004 Mar;7 Suppl 1:S21-5. Review.

PMID:
14972081
17.

Consensus on the Practical Use of Amisulpride, an Atypical Antipsychotic, in the Treatment of Schizophrenia.

Lecrubier Y, Azorin M, Bottai T, Dalery J, Garreau G, Lempérière T, Lisoprawski A, Petitjean F, Vanelle JM.

Neuropsychobiology. 2001;44(1):41-6. Review.

PMID:
11408792
18.

Olanzapine pamoate: a stick in time? A review of the efficacy and safety profile of a new depot formulation of a second-generation antipsychotic.

Citrome L.

Int J Clin Pract. 2009 Jan;63(1):140-50. doi: 10.1111/j.1742-1241.2008.01900.x. Epub 2008 Oct 1. Review.

PMID:
18834452
19.

Drug safety evaluation of olanzapine pamoate.

Schöttle D, Kuhnigk O, Naber D.

Expert Opin Drug Saf. 2013 Nov;12(6):897-903. doi: 10.1517/14740338.2013.832753. Epub 2013 Sep 12. Review.

PMID:
24024627
20.

The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychotics.

Leucht S, Winter-van Rossum I, Heres S, Arango C, Fleischhacker WW, Glenthøj B, Leboyer M, Leweke FM, Lewis S, McGuire P, Meyer-Lindenberg A, Rujescu D, Kapur S, Kahn RS, Sommer IE.

Schizophr Bull. 2015 May;41(3):549-58. doi: 10.1093/schbul/sbv019. Epub 2015 Mar 18. Review.

Supplemental Content

Support Center